3 High-Yield Stocks at 52-Week Lows Worth Buying
💡 Puntos Clave
Sanofi, AT&T, and Vici Properties offer compelling entry points with high dividends and attractive valuations despite recent declines.
Bargain Hunting: Three High-Yield Stocks Hit New Lows
Sanofi (SNY), AT&T (T), and Vici Properties (VICI) recently touched new 52-week lows, presenting potential opportunities for income-focused investors. Sanofi is down 12% year-to-date despite strong first-quarter revenue growth of 14% at constant exchange rates, driven by a 31% jump in Dupixent sales. The stock now trades at 19 times trailing earnings with a 5.7% dividend yield.
AT&T has fallen 17% in 2026 amid concerns about SpaceX's Starlink mobile service competing in the telecom space. However, the article argues the market may be overreacting, noting AT&T's stable business and incredibly low price-to-earnings multiple of 7. Its dividend yield has risen to 5.3%.
Vici Properties, a casino and entertainment REIT, is down just 5% this year but still hit a new low. It offers the highest yield at 6.7% and has shown strong funds from operations (FFO) growth, with FFO per share rising to $0.82 from $0.51 a year earlier. The quarterly dividend of $0.45 is well-covered.
All three stocks are supported by solid fundamentals: Sanofi's robust pipeline, AT&T's reliable cash flow, and Vici's stable property portfolio. The low valuations and high yields make them attractive for dividend investors seeking income with a margin of safety.
However, risks remain: Sanofi faces patent expiration for Dupixent by 2031, AT&T deals with competitive threats from Starlink, and Vici depends on the casino industry's health. Yet the current prices may already reflect these concerns.
Why These Dividend Stocks Matter Now
For income investors, buying high-quality dividend stocks at 52-week lows can lock in outsized yields. Sanofi's 5.7% yield is supported by strong free cash flow and a pipeline with 28 phase 3 trials, reducing the risk from patent cliffs. AT&T's 5.3% yield comes with a valuation that prices in significant competitive pressure, but its core business remains durable and generates steady cash flow.
Vici's 6.7% yield is particularly attractive given its low volatility and defensive nature as a REIT. The company's FFO growth demonstrates its ability to maintain and grow distributions. With interest rate expectations potentially peaking, REITs like Vici could see valuation support.
If you hold these stocks, the current lows may be a chance to average down. If you don't, initiating positions now combines high current income with potential capital appreciation as fears subside. The key is that all three have manageable risks relative to their dividend payouts and business strength.
Investors should monitor regulatory and competitive developments, but the margin of safety offered by these depressed prices makes them compelling long-term holds for a diversified income portfolio.
Fuente: The Motley Fool
Análisis generado por el modelo cuantitativo de Bobby AI, revisado y editado por nuestro equipo de investigación. Esto no constituye asesoramiento financiero. Investigue por su cuenta antes de tomar decisiones de inversión.
Bobby Insight
Bargain hunters should consider buying SNY, T, and VICI at current levels for high income and potential upside.
All three stocks offer strong dividend yields supported by solid fundamentals. Sanofi's patent concerns are overblown given its pipeline. AT&T's competitive threats are likely overstated, and Vici's REIT structure provides stability. Current valuations provide a margin of safety.
¿Cómo Me Afecta?
